The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-03-07 and is reviewed periodically as new material appears.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
=== University of Nebraska Medical Center === Markin was awarded the Ida Ittner Postdoctoral Fellowship studying lead toxicity in children from 1980 to 1982, working in the laboratory of Dr. Carol R. Angle. In 2005, Markin was named the David T. Purtilo Professor of Pathology and Microbiology. Markin helped develop Children's Specialty Physicians, the pediatric practice plan for the UNMC College of Medicine at Children's Hospital & Medical Center. Markin also holds appointments in the Departments of Surgery and Psychiatry. Markin was inducted into the National Academy of Inventors Fellows Class of 2015. He has also received the Lifetime Achievement Award from UNeMed Corporation, UNMC's technology transfer office, for his innovations that have transformed the clinical laboratory. Markin leads the telehealth initiative of UNMC and Nebraska Medicine. Since 2011, he has served as associate vice chancellor for business development and as chief technology officer. In October 2005, the U.S. Defense Department provided a grant to Markin and his team to design a new method for microbiology automation. Known as the Microbiology Automation Research Project, or "MARP," the project is designed to develop a broad platform that can be used in the clinical laboratory, including applications for bacteriology, mycology and virology. Additionally, the project has potential uses for other applications, including bioterrorism testing, and holds significant promise for the civilian sector. Markin holds several patents, and has written numerous industry articles on laboratory automation.
== Further reading == Zhu KW (2023). "Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials". Frontiers in Pharmacology. 14 1228548. doi:10.3389/fphar.2023.1228548. PMC 10484631. PMID 37693894.
=== Cross-country same-day delivery === In October 2019, Roadie and Delta Cargo launched DASH Door-to-Door, a 24/7 door-to-door pick-up and delivery service. Roadie handles the first and last mile and Delta manages the line haul via passenger flights. The service launched originally from Atlanta to 55 cities and is an industry-first for a US commercial airline.
Sources: en.wikipedia.org
He also wrote the music and the lyrics to "Hate to Feel", "Angry Chair" and "Head Creeps", and melodies to other songs. Staley's lyrics are largely viewed as having dealt with his personal troubles, such as drug use and depression. Staley also played guitar on "Angry Chair" and "Hate to Feel". Cantrell said of "Angry Chair" on the liner notes of the 1999 Music Bank box set:
== Universities == According to the 2020 QS World University Rankings, Chulalongkorn University (CU) was ranked 247th in the world and earned the top ranking in Thailand for the seventh consecutive year. Also ranked were Mahidol University (314th), and Chiang Mai University and Thammasat University (both in the 601–650 tranche), and four other Thai universities in the 801–1,000 tranche. The Times Higher Education Asia University Rankings 2018 ranked Mahidol University as the top Thai institution. It ranked 97 of some 350 universities (1=best; 350=lowest). King Mongkut's University of Technology Thonburi was ranked 116, Chulalongkorn University 164, and Suranaree University of Technology 168. Thailand had no other universities in the top 200. Chulalongkorn University was ranked number one in Thailand and 45th in Asia in 2016. Mahidol University was ranked the top Thai university among the top 200 Asian (including Middle Eastern) universities in 2016 by Times Higher Education Asia University Rankings 2016.
== Early life and education == Harriet Jane Lawrence was born on September 13, 1883, in Kingsbury, Maine. She began working as a teacher at the age of fifteen and used her earnings to help finance her continued education. Through savings from her teaching work, she was able to pursue higher education and eventually enroll in medical school. Lawrence attended Boston University School of Medicine, where she earned her medical degree in 1912. She was one of six women in her graduating class at a time when women remained significantly underrepresented in medical education. She later received the 1963 Distinguished Alumni Award from Boston University in acknowledgment of her contributions to medicine and work to advance women in the field.
=== DNA chips === Early biochips were based on the idea of a DNA microarray, e.g., the GeneChip DNAarray from Affymetrix, which is a piece of glass, plastic or silicon substrate, on which pieces of DNA (probes) are affixed in a microscopic array. Similar to a DNA microarray, a protein array is a miniature array where a multitude of different capture agents, most frequently monoclonal antibodies, are deposited on a chip surface; they are used to determine the presence and/or amount of proteins in biological samples, e.g., blood. A drawback of DNA and protein arrays is that they are neither reconfigurable nor scalable after manufacture. Digital microfluidics has been described as a means for carrying out Digital PCR.
Sources: en.wikipedia.org
Next, he co-starred in the action Lucy (2014), about a woman (Scarlett Johansson) who gains psychokinetic abilities when a nootropic drug is absorbed into her bloodstream. Freeman plays Professor Samuel Norman, who helps her research the condition. Producer Virginie Silla wanted Freeman for the part because of his experience in portraying a character of wisdom. "He was the perfect actor", she said. Upon the release of Lucy, critical reception ranged from mixed-to-positive. In the same year Freeman appeared in Dolphin Tale 2, the sequel to 2011's Dolphin Tale, and 5 Flights Up, a comedy-drama. At the end of 2014, Freeman appeared as himself, among other celebrities, in the documentary Lennon or McCartney.
In 2012, under prosecution by the United States Department of Justice (DoJ) based on combined investigations of the Department of Health and Human Services (HHS-OIG), FDA and FBI, primarily concerning sales and marketing of the drugs Avandia, Paxil and Wellbutrin, GSK pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data and kickbacks to physicians in the United States and agreed to pay a US$3 billion (£1.9bn) settlement. It was the largest health-care fraud case to date in the US and the largest settlement in the pharmaceutical industry.
The mechanism of action of bottromycin was confirmed nearly 20 years following the discovery of bottromycin. Bottromycin functions as an antibiotic through inhibition of protein synthesis. It blocks aminoacyl tRNA binding to the ribosome by binding to the A site of the 50s subunit. This results in release of aminoacyl tRNA from the ribosome and premature termination of protein synthesis. A comparison of other antibiotics known to bind to the A site of the ribosome, including micrococcin, tetracycline, streptomycin, and chloramphenicol, suggested that only bottromycin and chloramphenicol caused release of aminoacyl tRNA from the ribosome. Of those antibiotics, only micrococcin is also a macrocyclic peptide.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.